Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference Jan 11, 2024 08:15AM
Fortress Biotech Reports Record 2022 Financial Results and Recent Corporate Highlights Mar 30, 2023 04:10PM
Checkpoint Therapeutics to Participate in the B. Riley Securities’ 3rd Annual Oncology Conference Jan 17, 2023 08:30AM
Fortress Biotech Reports First Quarter 2022 Financial Results and Recent Corporate Highlights May 12, 2022 04:01PM
Checkpoint Therapeutics to Present at the Virtual Fortress Biotech R&D Summit Hosted by B. Riley Securities Apr 4, 2022 08:15AM


Apr 4, 2022 08:15AM Checkpoint Therapeutics to Present at the Virtual Fortress Biotech R&D Summit Hosted by B. Riley Securities
Apr 1, 2022 08:30AM Fortress Biotech Announces Virtual Two-Day R&D Summit Hosted by B. Riley Securities on Tuesday, April 5 and Wednesday, April 6, 2022
Apr 1, 2022 08:30AM Fortress Biotech Announces Virtual Two-Day R&D Summit Hosted by B. Riley Securities on Tuesday, April 5 and Wednesday, April 6, 2022
Jan 25, 2022 04:30PM Checkpoint Therapeutics to Participate in the B. Riley Securities’ Virtual Oncology Conference
Jan 25, 2022 04:30PM Checkpoint Therapeutics to Participate in the B. Riley Securities’ Virtual Oncology Conference
Jan 6, 2021 08:30AM Checkpoint Therapeutics to Participate in Three January 2021 Virtual Investor Conferences
Jan 6, 2021 08:30AM Checkpoint Therapeutics to Participate in Three January 2021 Virtual Investor Conferences
Aug 17, 2020 08:00AM Checkpoint Therapeutics to Present at Virtual Corporate Access Summit Hosted by B. Riley FBR on Wednesday, August 19, 2020
Aug 17, 2020 08:00AM Checkpoint Therapeutics to Present at Virtual Corporate Access Summit Hosted by B. Riley FBR on Wednesday, August 19, 2020
Aug 12, 2020 07:30AM Fortress Biotech Announces Virtual Two-Day Corporate Access Summit Hosted by B. Riley FBR on Tuesday, August 18 and Wednesday, August 19, 2020
Dec 21, 2018 01:17PM Fortress Biotech Recaps Corporate Highlights and Achievements in 2018
Aug 2, 2018 09:07AM Special Report: Biotech incubator taps investors through in-house brokerage